Paraphrase the following paragraph.
There can be no question that, for the purpose of replying to the referring courts, it is irrelevant that the marketing authorisations granted in Switzerland do not enable the medicinal products which they protect to be traded within EEA territory, other than Liechtenstein.
The fact that the marketing authorisations issued in Switzerland do not allow the transit of the medicines to which they provide protection within the territory of the EEA with the exception of Liechtenstein is clearly irrelevant for the purposes of answering the questions of the national courts.